The Government of Canada amended the Food and Drugs Act (Vanessa's Law - Bill C-17) to include the requirement that both positive and negative decisions about drug authorizations be disclosed on a public website, and clinical trial information be disclosed on a public registry. The amendments would enable Health Canada to strengthen its Regulatory Transparency and Openness Framework announced by the Minister in April 2014.
Health Canada - Amendments to the Food and Drugs Act (Bill C-17)